Examined the relationship of the MMPI high‐point codes and the diagnostic system of the Diagnostic Statistical Manual III of the American Psychiatric Association. Five psychiatrists reanalyzed the patients' records and rendered a DSM‐III diagnosis. In all, 24 code types were identified from the private psychiatric clinic sample (N = 261). The resulting clusters of diagnostic classification are presented, and, additionally, a narrative summation for each code type is given.

Literature on forgetting rates is reviewed and related methodological issues are discussed. Descriptive data from 50 subjects are provided for tests which were developed to assess forgetting rates for words, pictures and designs. The three tests are well-matched on initial learning at criterion and have comparable variance and skewness of score distributions. Forgetting rates were similar across the initial 10-min retention interval, but there was a more rapid loss of words than pictures and designs from 10 min to 2 hr, especially in male subjects. Memory for words and pictures steadily declined between 10 min and 48 hr, but there was no further loss for designs after 2 hr. These findings suggest that nonverbal memory storage is more stable than verbal memory storage over intervals of hours to days. Modest sex differences are discussed in terms of potential differences in organization of brain function. The potential utility of these tests in further elucidating the nature of memory impairment in clinical populations is addressed.

No abstract

With increasing numbers of surviving head injured children and adolescents, there is a growing need to provide child neuropsychiatric services as a necessary component for their comprehensive rehabilitation. This paper discusses the critical role child psychiatry should have in pediatric head injury rehabilitation and outlines a framework for neuropsychiatric interventions including the use of neuropsychoactive medications. Case examples highlight the principles and practicalities of interventions.

For several years carbamazepine has been used to treat intractable mania and it is frequently used in combination with lithium. Reports of toxicity have appeared in the past 2 years and some risk factors have been suggested. This paper reports four cases of brain-damaged adolescents treated with carbamazepine and lithium for both seizure and behaviour control who developed this reported neurotoxic phenomenon.